SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-018419
Filing Date
2022-09-13
Accepted
2022-09-13 16:47:24
Documents
109
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K cntb-20220630.htm   iXBRL 6-K 3555721
2 EX-99.1 cntb-ex99_1.htm EX-99.1 560232
  Complete submission text file 0000950170-22-018419.txt   14006464

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntb-20220630_cal.xml EX-101.CAL 73745
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntb-20220630_pre.xml EX-101.PRE 450748
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntb-20220630.xsd EX-101.SCH 96958
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntb-20220630_lab.xml EX-101.LAB 555453
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntb-20220630_def.xml EX-101.DEF 238477
103 EXTRACTED XBRL INSTANCE DOCUMENT cntb-20220630_htm.xml XML 3289370
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 221241261
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences